Patient-specific meta-analysis of 3 validation studies of the 12-gene colon cancer recurrence score assay for recurrence risk assessment after surgery with or without 5FU and oxaliplatin.

Greg Yothers,Alan P. Venook,Takeharu Yamanaka,Yan Lin,Michael Crager,Calvin Chao,Frederick L. Baehner,Takayuki Yoshino

Patient-specific meta-analysis of 3 validation studies of the 12-gene colon cancer recurrence score assay for recurrence risk assessment after surgery with or without 5FU and oxaliplatin.

2021

Greg Yothers
Alan P. Venook
Takeharu Yamanaka
Yan Lin
Michael Crager
Calvin Chao
Frederick L. Baehner
Takayuki Yoshino

3599Background: The 12-gene Oncotype DX Colon Recurrence Score assay is a clinically validated genomic assay that evaluates recurrence risks in stage II and stage III colon cancer patients independ...

Keywords:

Internal medicine
Oxaliplatin
Oncotype DX
Medicine
recurrence risk
patient specific
Meta-analysis
Colorectal cancer
Oncology
Stage III Colon Cancer
recurrence score

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations